Brief: Erasca Announces FDA Clearance Of IND Application For ERAS-3490

Erasca

13/12/2022 13:31

Dec 13 (Reuters) - Erasca Inc  ERAS.O :
    * ERASCA ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR
CNS-PENETRANT KRAS G12C INHIBITOR ERAS-3490 IN KRAS G12C-MUTATED
ADVANCED OR METASTATIC SOLID TUMORS

Source text for Eikon:  ID:nGNX9L89F8 
Further company coverage:  ERAS.O 
 ((Reuters.Briefs@thomsonreuters.com;))